Flexible sigmoidoscopy as a mass screening tool : Screening for bowel cancer.
Endoscopic removal of premalignant adenomas from the distal bowels of the entire population, 3 to 5-yearly from age 50, is advocated in the US as a feasible method of reducing colorectal cancer mortality rates.
In the UK, a single flexible sigmoidoscopy (FS) is regarded as a more cost-effective option.
Although more acceptable than colonoscopy, FS and polypectomy are expensive and invasive procedures carrying a small risk of serious harm.
We believe that, before implementing mass screening, precise estimates are required of the magnitude of the reduction in mortality and costs (financial, physical and emotional).
Several randomized trials, including a large British study, are currently evaluating these aspects.
Mots-clés Pascal : Carcinome, Côlon, Rectum, Dépistage, Grande dimension, Sigmoïdoscopie, Flexibilité, Evaluation performance, Homme, Tumeur maligne, Appareil digestif pathologie, Intestin pathologie, Côlon pathologie, Rectum pathologie, Endoscopie
Mots-clés Pascal anglais : Carcinoma, Colon, Rectum, Medical screening, Large dimension, Sigmoidoscopy, Flexibility, Performance evaluation, Human, Malignant tumor, Digestive diseases, Intestinal disease, Colonic disease, Rectal disease, Endoscopy
Notice produite par :
Inist-CNRS - Institut de l'Information Scientifique et Technique
Cote : 98-0230453
Code Inist : 002B13B01. Création : 11/09/1998.